Necroptosis: A novel therapeutic target for glioblastoma

Medical Hypotheses

Volumn 76, Issue 3, 2011, Pages 350-352

  Jiang, Yu Gang ^a   Peng, Yong ^a   Koussougbo, Koku Sossou ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RESISTANCE; CARCINOGENESIS; CELL DEATH; CELL PROLIFERATION; GLIOBLASTOMA; HUMAN; LIFE EXPECTANCY; NECROPTOSIS; NECROSIS; TUMOR CELL; TUMOR NECROSIS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BRAIN NEOPLASMS; GLIOBLASTOMA; HUMANS; MODELS, BIOLOGICAL; NECROSIS; SIGNAL TRANSDUCTION;

EID: 79751524886     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2010.10.037     Document Type: Article

References (38)

1. Hotchkiss R.S., Strasser A., McDunn J.E., Swanson P.E. Cell death. N Engl J Med 2009, 361:1570-1583.
2. Hitomi J., Christofferson D.E., Ng A., et al. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 2008, 135:1311-1323.
3. Galluzzi L., Kroemer G. Necroptosis: a specialized pathway of programmed necrosis. Cell 2008, 135:1161-1163.
4. Wen P.Y., Kesari S. Malignant gliomas in adults. N Engl J Med 2008, 359:492-507.
5. Lefranc F., Facchini V., Kiss R. Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas. Oncologist 2007, 12:1395-1403.
6. Krakstad C., Chekenya M. Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics. Mol Cancer 2010, 9:135.
7. Raza S.A., Lang F.F., Aggarwal B.B., Fuller G.N., Wildrick D.A., Sawaya R. Necrosis and glioblastoma: a friend or a foe? A review and a hypothesis. Neurosurgery 2002, 51:2-12.
8. Hammoud M.A., Sawaya R., Shi W.M., Thall P.F., Leeds N.E. Prognostic significance of preoperative MRI scans in glioblastoma multiforme. J Neurooncol 1996, 27:65-73.
9. Lacroix M., Abi-Said D., Fourney D.R., et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 2001, 95:190-198.
10. Jensen R.L. Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target. J Neurooncol 2009, 92:317-335.
11. Nicotera P., Melino G. Regulation of the apoptosis-necrosis switch. Oncogene 2004, 23:2757-2765.
12. Brat D.J., Van Meir E.G. Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma. Lab Invest 2004, 84:397-405.
13. Ricci M.S., Zong W.X. Chemotherapeutic approaches for targeting cell death pathways. Oncologist 2006, 11:342-357.
14. Hu X., Han W., Li L. Targeting the weak point of cancer by induction of necroptosis. Autophagy 2007, 3:490-492.
15. Hu X., Xuan Y. Bypassing cancer drug resistance by activating multiple death pathways - a proposal from the study of circumventing cancer drug resistance by induction of necroptosis. Cancer Lett 2008, 259:127-137.
16. Barker F.G., Davis R.L., Chang S.M., Prados M.D. Necrosis as a prognostic factor in glioblastoma multiforme. Cancer 1996, 77:1161-1166.
17. Brat D.J., Castellano-Sanchez A.A., Hunter S.B., et al. Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Res 2004, 64:920-927.
18. Xie T.X., Aldape K.D., Gong W., et al. Aberrant NF-kappaB activity is critical in focal necrosis formation of human glioblastoma by regulation of the expression of tissue factor. Int J Oncol 2008, 33:5-15.
19. Vakkila J., Lotze M.T. Inflammation and necrosis promote tumour growth. Nat Rev Immunol 2004, 4:641-648.
20. Edwards J.G., Swinson D.E., Jones J.L., Muller S., Waller D.A., O'Byrne K.J. Tumor necrosis correlates with angiogenesis and is a predictor of poor prognosis in malignant mesothelioma. Chest 2003, 124:1916-1923.
21. Bassi R., Giussani P., Anelli V., et al. HMGB1 as an autocrine stimulus in human T98G glioblastoma cells: role in cell growth and migration. J Neurooncol 2008, 87:23-33.
22. Rong Y., Durden D.L., Van Meir E.G., Brat D.J. 'Pseudopalisading' necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis. J Neuropathol Exp Neurol 2006, 65:529-539.
23. Kroemer G., Galluzzi L., Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007, 87:99-163.
24. Stegh A.H., Kesari S., Mahoney J.E., et al. Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma. Proc Natl Acad Sci USA 2008, 105:10703-10708.
25. Rong Y., Post D.E., Pieper R.O., Durden D.L., Van Meir E.G., Brat D.J. PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma. Cancer Res 2005, 65:1406-1413.
26. He S., Wang L., Miao L., et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009, 137:1100-1111.
27. Zhang D.W., Shao J., Lin J., et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 2009, 325:332-336.
28. Cho Y.S., Challa S., Moquin D., et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 2009, 137:1112-1123.
29. Proskuryakov S.Y., Gabai V.L. Mechanisms of tumor cell necrosis. Curr Pharm Des 2010, 16:56-68.
30. Zong W.X., Ditsworth D., Bauer D.E., Wang Z.Q., Thompson C.B. Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev 2004, 18:1272-1282.
31. Ha H.C., Snyder S.H. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci USA 1999, 96:13978-13982.
32. Guerriero J.L., Ditsworth D., Fan Y., Zhao F., Crawford H.C., Zong W.X. Chemotherapy induces tumor clearance independent of apoptosis. Cancer Res 2008, 68:9595-9600.
33. Scholz C., Wieder T., Starck L., et al. Arsenic trioxide triggers a regulated form of caspase-independent necrotic cell death via the mitochondrial death pathway. Oncogene 2005, 24:1904-1913.
34. Hsieh Y.J., Wu C.C., Chang C.J., Yu J.S. Subcellular localization of photofrin determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: when plasma membranes are the main targets. J Cell Physiol 2003, 194:363-375.
35. Miccoli L., Beurdeley-Thomas A., De Pinieux G., et al. Light-induced photoactivation of hypericin affects the energy metabolism of human glioma cells by inhibiting hexokinase bound to mitochondria. Cancer Res 1998, 58:5777-5786.
36. Fabris C., Valduga G., Miotto G., et al. Photosensitization with zinc (II) phthalocyanine as a switch in the decision between apoptosis and necrosis. Cancer Res 2001, 61:7495-7500.
37. Han W., Li L., Qiu S., et al. Shikonin circumvents cancer drug resistance by induction of a necroptotic death. Mol Cancer Ther 2007, 6:1641-1649.
38. Raza S.M., Fuller G.N., Rhee C.H., et al. Identification of necrosis-associated genes in glioblastoma by cDNA microarray analysis. Clin Cancer Res 2004, 10:212-221.